As of Nov 19, 2026, 1 of 1 active firms rate EVO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EVO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.01
Range $-0.01 – $-0.01 · 1 analysts · -97% YoY
Next period, 1 analysts expect Evotec SE ADR to earn $-0.01 a share (range $-0.01 – $-0.01), versus $-0.34 a year earlier. Full-year consensus is $-1.34, growing to $0.08 the year after.
REVENUE · NEXT QUARTER
$158.8M
Range $145.2M – $172.4M · 1 analysts · +1% YoY
Revenue is expected to reach $158.8M (range $145.2M – $172.4M), +1.4% year-over-year. Full-year consensus is $599.7M, rising to $708.6M next year.
Top analysts covering Evotec SE ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EVO.
#1
Douglas Tsao
HC Wainwright & Co. · Rank #312
Buy
$7.00+377.8% to target
Overall win rate
35%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$4.00+173.0% to target
Overall win rate
38%
+ Follow
#3
Michael Ryskin
B of A Securities
Sell
$2.40+63.8% to target
Coverage
—
+ Follow
#4
BS
Brendan Smith
TD Cowen
Neutral
$2.00+36.5% to target
Coverage
—
+ Follow
EVO stock forecast FAQ
What is EVO's average 12-month price target?+
The 1 active firms with a live target average $4.00 for Evotec SE ADR over the next 12 months, ranging from a $4.00 high to a $4.00 low, as of Nov 19, 2026.
Is EVO stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover EVO?+
1 active firms have a recognized rating on Evotec SE ADR as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EVO?+
Among analysts who currently cover EVO, Douglas Tsao of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #312). Their current call is Buy with a $7.00 target.
What is Evotec SE ADR's projected EPS for next quarter?+
The consensus estimate is $-0.01 per share (range $-0.01 – $-0.01) across 1 analysts. Full-year EPS is projected at $-1.34, rising to $0.08 the following year.
How much revenue is Evotec SE ADR expected to report next quarter?+
Consensus revenue is $158.8M (range $145.2M – $172.4M). Full-year revenue is projected at $599.7M, growing to $708.6M next year.
Have analysts been upgrading or downgrading EVO lately?+
As of Nov 19, 2026, 1 of 1 active firms rate EVO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EVO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.